Please login to the form below

Not currently logged in
Email:
Password:

Capital investment

This page shows the latest Capital investment news and features for those working in and with pharma, biotech and healthcare.

Coronavirus disruption scuppers Curium Pharma sale

Coronavirus disruption scuppers Curium Pharma sale

Three potential buyers for Curium – said to include investment groups Nordic Capital, Bain Capital and CVC Capital Partners – are said to have lowered their bids for France-based Curium amid turmoil

Latest news

  • AstraZeneca launches $1bn Chinese investment fund AstraZeneca launches $1bn Chinese investment fund

    ups. The Healthcare Industrial Fund, set up with and led by investment bank China International Capital Corporation (CICC), will focus initially on companies at the Wuxi International Life Science Innovation Campus, ... The announcement of the new

  • Hancock says UK will consider mandatory vaccinations Hancock says UK will consider mandatory vaccinations

    Hospital investment. The revelation almost threatened to distract attention from the Conservatives’ flagship health policy statement at the conference, namely that the government intends to spend £13bn ($16bn) on capital investment ... NHS

  • Johnson pledges £200m cash injection into UK’s life sciences sector Johnson pledges £200m cash injection into UK’s life sciences sector

    The investment aims to help companies within the sector to raise capital – to run clinical trials, employ more industrial scientists and develop manufacturing capabilities. ... In addition, the Conservatives announced a new heath policy statement

  • RNA-focused biotech Storm Therapeutics raises extra £14m RNA-focused biotech Storm Therapeutics raises extra £14m

    investors. The additional funds come from Dublin-based life science venture capital firm  Seroba Life Sciences, and brings the biotech’s total Series A financing to £30m. ... The new money adds to existing investment from Cambridge Innovation Capital

  • Bicycle Therapeutics looks to raise $86m with IPO Bicycle Therapeutics looks to raise $86m with IPO

    The UK biotech sector has been thriving (despite Brexit) and has been less reliant on IPOs because it has been able to generate more capital from private investment; venture capital funding

More from news
Approximately 2 fully matching, plus 49 partially matching documents found.

Latest Intelligence

  • The changing nature of approvals – what does the future hold? The changing nature of approvals – what does the future hold?

    High-profile disinvestments include those by Pfizer and Eli Lilly. However, Pfizer has since announced that, together with investment firm Bain Capital, it has created a new drug company called Cerevel ... Regulatory processes in Mainland China have

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    This include specialist venture capital firms, which are upping their investment in the region, which is seen as underdeveloped compared to the sometime overheated Massachusetts and California biotech markets. ... As venture capital (VC) investors,

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    to encourage a home-grown pharma industry, as well as investment from multinational giant. ... Money flowing into Europe. Meanwhile, just as multinationals are increasing their investments in China, there is also a huge amount of investment capital

  • Drug pricing

  • European venture funding for the life science sector European venture funding for the life science sector

    The greater risk - given the inelasticity of the supply of R&D to the sudden increase in capital - is a lowering of the quality bar as marginal companies obtain investment. ... Keeping the bar high. To guard against this risk, it is essential that

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Anish Mehta appointed CEO of new women's health business Anish Mehta appointed CEO of new women's health business

    Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... London-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the international women’s health assets portfolio it acquired

  • David Horn Solomon takes the helm of Akari Therapeutics David Horn Solomon takes the helm of Akari Therapeutics

    Sanofi.”. His other roles have included CEO at Bionor Pharma and most recently he was at Nordic healthcare investment group Sund Capital where he was a managing partner.

  • IGEM Therapeutics appoints Dr Tim Wilson as CEO IGEM Therapeutics appoints Dr Tim Wilson as CEO

    has raised £2m from Epidarex Capital, in order to progress its pipeline of IgE antibody drug candidates. ... Wilson has over 28 years’ experience in the life sciences sector, ranging from venture capital and start-ups to investment banking and equity

  • BMS appoints three independent directors BMS appoints three independent directors

    Samuels also brings considerable business and operational experience to the position, with a particular expertise in economics, capital markets and investment decision-making. ... He currently serves as a director at Perrigo Company and Stamps.com, and

  • Dr Stephen Hoffman joins Bicycle Therapeutics Dr Stephen Hoffman joins Bicycle Therapeutics

    Dr Hoffman brings 30 years of experience in the pharmaceutical and financial industries to the biotech, currently serving as a senior advisor to PDL BioPharma and president of 10x Capital, an ... investment management firm.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics